The Power of Investment in Growth and Innovation
At Allergan, we have a strong commitment to investing in innovation to improve the lives of patients by addressing difficult to treat diseases. While investing in scientific innovation can be risky, a supportive legal and regulatory environment, as well as access to skilled workers and strong academic partners, creates an environment for success.
Antibiotic Resistance – a Threat that Isn’t Going Away. Last week the White House called on Congress to shift leftover Federal funds from the...
NIH Funding Fuels Innovation & Open Science. I felt very optimistic about the future of our Open Science model after reading that the U.S. Congress increased NIH funding of biomedical innovation by $2 billion. In a recent Wall Street Journal article NIH director Francis Collins shared...
Page 3 of 3